David Rescott
Stock Analyst at Baird
(3.61)
# 745
Out of 4,842 analysts
59
Total ratings
53.06%
Success rate
5.67%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintains: Neutral | $94 → $92 | $81.24 | +13.24% | 5 | May 22, 2025 | |
| LIVN LivaNova | Maintains: Outperform | $55 → $61 | $42.79 | +42.56% | 4 | May 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $111 → $110 | $94.51 | +16.39% | 3 | Apr 25, 2025 | |
| PEN Penumbra | Maintains: Buy | $315 → $330 | $264.29 | +24.86% | 29 | Apr 24, 2025 | |
| EW Edwards Lifesciences | Maintains: Neutral | $72 → $75 | $76.66 | -2.17% | 4 | Apr 24, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $115 → $120 | $104.51 | +14.82% | 5 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $600 → $575 | $552.41 | +4.09% | 3 | Apr 23, 2025 | |
| SIBN SI-BONE | Maintains: Buy | $25 → $26 | $18.49 | +40.65% | 6 | Dec 22, 2023 |
Medtronic
May 22, 2025
Maintains: Neutral
Price Target: $94 → $92
Current: $81.24
Upside: +13.24%
LivaNova
May 8, 2025
Maintains: Outperform
Price Target: $55 → $61
Current: $42.79
Upside: +42.56%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111 → $110
Current: $94.51
Upside: +16.39%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $315 → $330
Current: $264.29
Upside: +24.86%
Edwards Lifesciences
Apr 24, 2025
Maintains: Neutral
Price Target: $72 → $75
Current: $76.66
Upside: -2.17%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $115 → $120
Current: $104.51
Upside: +14.82%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600 → $575
Current: $552.41
Upside: +4.09%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25 → $26
Current: $18.49
Upside: +40.65%